Press Releases Events & Presentations Event Details 2023 International HBV Meeting Sep 19 - Sep 23, 2023 Supporting Materials HBV/HDV entry inhibitor - Pre-clinical profiling of a novel class of orally bioavailable small molecules potently inhibiting hepatitis B and D virus entry 1.9 MB ABI-4334 - ABI-4334, a novel inhibitor of hepatitis B virus core protein, disrupts DL-DNA containing capsids and prevents HBV DNA integration 1.1 MB Interferon-α Receptor Agonist: Pre-clinical characterization of novel liver-focused small molecules efficiently inhibiting hepatitis B virus by activating type I interferon signaling 1.4 MB Shareholder Tools Print Email Alerts RSS News Feeds Search Investors
2023 International HBV Meeting Sep 19 - Sep 23, 2023 Supporting Materials HBV/HDV entry inhibitor - Pre-clinical profiling of a novel class of orally bioavailable small molecules potently inhibiting hepatitis B and D virus entry 1.9 MB ABI-4334 - ABI-4334, a novel inhibitor of hepatitis B virus core protein, disrupts DL-DNA containing capsids and prevents HBV DNA integration 1.1 MB Interferon-α Receptor Agonist: Pre-clinical characterization of novel liver-focused small molecules efficiently inhibiting hepatitis B virus by activating type I interferon signaling 1.4 MB
HBV/HDV entry inhibitor - Pre-clinical profiling of a novel class of orally bioavailable small molecules potently inhibiting hepatitis B and D virus entry 1.9 MB
ABI-4334 - ABI-4334, a novel inhibitor of hepatitis B virus core protein, disrupts DL-DNA containing capsids and prevents HBV DNA integration 1.1 MB
Interferon-α Receptor Agonist: Pre-clinical characterization of novel liver-focused small molecules efficiently inhibiting hepatitis B virus by activating type I interferon signaling 1.4 MB
